newsfilter
← Latest News
GlobeNewswire·

Eliem Therapeutics at the 5th Annual Evercore ISI HealthCONx Virtual Conference

SEATTLE and CAMBRIDGE, United Kingdom, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (NASDAQ:ELYM), a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability